PL3710445T3 - Sposób wytwarzania raltegrawiru - Google Patents

Sposób wytwarzania raltegrawiru

Info

Publication number
PL3710445T3
PL3710445T3 PL18807004T PL18807004T PL3710445T3 PL 3710445 T3 PL3710445 T3 PL 3710445T3 PL 18807004 T PL18807004 T PL 18807004T PL 18807004 T PL18807004 T PL 18807004T PL 3710445 T3 PL3710445 T3 PL 3710445T3
Authority
PL
Poland
Prior art keywords
raltegravir
preparation
Prior art date
Application number
PL18807004T
Other languages
English (en)
Inventor
Francesco Caputo
Daniele Vigo
Oreste Piccolo
Original Assignee
Cambrex Profarmaco Milano S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambrex Profarmaco Milano S.R.L. filed Critical Cambrex Profarmaco Milano S.R.L.
Publication of PL3710445T3 publication Critical patent/PL3710445T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18807004T 2017-11-14 2018-11-13 Sposób wytwarzania raltegrawiru PL3710445T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT201700130030 2017-11-14
EP18807004.9A EP3710445B1 (en) 2017-11-14 2018-11-13 Process for the preparation of raltegravir
PCT/EP2018/081042 WO2019096773A1 (en) 2017-11-14 2018-11-13 Process for the preparation of raltegravir

Publications (1)

Publication Number Publication Date
PL3710445T3 true PL3710445T3 (pl) 2022-06-20

Family

ID=61527266

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18807004T PL3710445T3 (pl) 2017-11-14 2018-11-13 Sposób wytwarzania raltegrawiru

Country Status (9)

Country Link
US (1) US11246869B2 (pl)
EP (1) EP3710445B1 (pl)
CA (1) CA3080012A1 (pl)
ES (1) ES2909302T3 (pl)
HR (1) HRP20220613T1 (pl)
IL (1) IL274560A (pl)
PL (1) PL3710445T3 (pl)
SI (1) SI3710445T1 (pl)
WO (1) WO2019096773A1 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1441735T1 (sl) 2001-10-26 2006-06-30 Angeletti P Ist Richerche Bio N-substituirani hidroksipirimidinon-karboksamidniinhibitorji HIV-integraze
UA87884C2 (uk) 2004-12-03 2009-08-25 Мерк Энд Ко., Инк. Безводна кристалічна калієва сіль інгібітора віл-інтегрази
EP2231621B1 (en) 2008-01-08 2016-11-02 Merck Sharp & Dohme Corp. Process for preparing n-substituted hydroxypyrimidinone carboxamides
US10259778B2 (en) 2014-11-10 2019-04-16 Aurobindo Pharma Ltd Process for the preparation of raltegravir

Also Published As

Publication number Publication date
EP3710445B1 (en) 2022-03-16
CA3080012A1 (en) 2019-05-23
ES2909302T3 (es) 2022-05-06
IL274560A (en) 2020-06-30
US11246869B2 (en) 2022-02-15
SI3710445T1 (sl) 2022-05-31
HRP20220613T1 (hr) 2022-06-24
US20200330466A1 (en) 2020-10-22
WO2019096773A1 (en) 2019-05-23
EP3710445A1 (en) 2020-09-23

Similar Documents

Publication Publication Date Title
IL276917A (en) A process for the preparation of alubixivet
SI3433285T1 (sl) Izboljšan postopek za pripravo sugamadeksa
ZA201706795B (en) Process for the preparation of dicycloplatin
IL260465B (en) A process for preparing an antibody-rifamycin conjugate
EP3694499A4 (en) NEW LIFITEGRAST PREPARATION PROCESS
PL3765440T3 (pl) Sposób wytwarzania n-alkilonitratoetylonitroamin
IL268835B (en) A process for the preparation of 2-cyanoimidazole compounds
PL3199516T3 (pl) Sposób wytwarzania Metaraminolu
IL281254A (en) A process for the preparation of lanbatinib
EP3177610A4 (en) Process for the preparation of polymorphic forms of nilotinib
IL275480A (en) A process for the preparation of pyrimidinyl-4-aminopyrazole compounds
IL275381A (en) A process for the preparation of Crisborole
EP3877361C0 (en) PROCESS FOR PREPARING ARYLSULFONYLPROPENENITRILE
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
ZA202002116B (en) Process for the preparation of piperine
PL3599256T3 (pl) Sposób wytwarzania poliorganosiloksanów
HUE053496T2 (hu) Eljárás izocianátok elõállítására
EP3523307A4 (en) METHOD FOR PRODUCING DORAOLZMID HYDROCHLORIDE
EP3474847A4 (en) METHOD FOR PRODUCING ELUXADOLIN
IL274560A (en) A process for the preparation of raltagravir
PT3102565T (pt) Processos para a preparação de intermediários de raltegravir
HUP1800278A2 (en) Process for the preparation of boc-linagliptin
IL274487B1 (en) A process for the preparation of fluoficolide
ZA201901052B (en) Process for the preparation of hydrogen
GB201713146D0 (en) Process for the preparation of glycidol